A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies
A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies
Not yet recruiting · NCT06906380 · Registry updated 2025-12-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, anemia, bone marrow disorder, hematologic disorder, leukemia, myelodysplastic syndrome, myelodysplastic syndrome with excess blasts, myelodysplastic syndrome with single lineage dysplasia, myeloid leukemia, neoplasm | Not yet recruiting | Not stated | 2025-12-08 | NCT06906380 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| ARCE Therapeutics, Inc. | 2 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| MD Anderson Cancer Center | Houston | United States | 589 |
| Novant Health Cancer Institute | Charlotte | United States | 8 |
| Novant Health Cancer Institute | Winston-Salem | United States | 2 |